Contents

Current Pharmaceutical Design, Volume 13 - Number 21

Src Inhibitors and Angiogenesis

, 13(21): 2118 - 2128

S. Schenone, F. Manetti and M. Botta


DOI: 10.2174/138161207781039580




Targeting Vascular Cell Migration as a Strategy for Blocking Angiogenesis: The Central Role of Focal Adhesion Protein Tyrosine Kinase Family

, 13(21): 2129 - 2145

A. Angelucci and M. Bologna


DOI: 10.2174/138161207781039643




Editorial [Hot Topic: New Potential Pharmaceutical Targets of Metabolic Syndrome (Executive Editors: Gianluca Iacobellis and Giuseppe Barbaro)]

, 13(21): 2146 - 2147

Gianluca Iacobellis and Giuseppe Barbaro


DOI: 10.2174/138161207781039607




Metabolic Syndrome and Adipose Tissue: New Clinical Aspects and Therapeutic Targets

, 13(21): 2148 - 2168

C.V. Iannucci, D. Capoccia, M. Calabria and F. Leonetti


DOI: 10.2174/138161207781039571




Visceral and Subcutaneous Adiposity: Are Both Potential Therapeutic Targets for Tackling the Metabolic Syndrome?

, 13(21): 2169 - 2175

Amaia Rodriguez, Victoria Catalan, Javier Gomez-Ambrosi and Gema Fruhbeck


DOI: 10.2174/138161207781039599




Homo obesus: A Metabotrophin-Deficient Species. Pharmacology and Nutrition Insight

, 13(21): 2176 - 2179

G.N. Chaldakov, M. Fiore, A.B. Tonchev, D. Dimitrov, R. Pancheva, G. Rancic and L. Aloe


DOI: 10.2174/138161207781039616




Epicardial Adipose Tissue As New Cardio-Metabolic Risk Marker and Potential Therapeutic Target in the Metabolic Syndrome

, 13(21): 2180 - 2184

Gianluca Iacobellis and Arya M. Sharma


DOI: 10.2174/138161207781039670




Dual Modulation of Vascular Function by Perivascular Adipose Tissue and Its Potential Correlation with Adiposity/Lipoatrophy-Related Vascular Dysfunction

, 13(21): 2185 - 2192

Yu-Jing Gao


DOI: 10.2174/138161207781039634




Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome

, 13(21): 2193 - 2198

Giuseppe Palasciano, Antonio Moschetta, Vincenzo O. Palmieri, Ignazio Grattagliano, Gianluca Iacobellis and Piero Portincasa


DOI: 10.2174/138161207781039652




Targeting the Liver in the Metabolic Syndrome: Evidence from Animal Models

, 13(21): 2199 - 2207

Michele Petruzzelli, Giuseppe Lo Sasso, Piero Portincasa, Giuseppe Palasciano and Antonio Moschetta


DOI: 10.2174/138161207781039625




Visceral Fat as Target of Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome

, 13(21): 2208 - 2213

Giuseppe Barbaro


DOI: 10.2174/138161207781039661




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science